Schizoaffective Disorders Completed Phase 2 Trials for Raloxifene (DB00481)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00206557The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot StudyTreatment